Regulatory T cells and tumor immunity Subhasis ChattopadhyayNitya G. ChakrabortyBijay Mukherji Review 03 May 2005 Pages: 1153 - 1161
CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype Javier G. CasadoRocío SotoRaquel Tarazona Original Article 12 May 2005 Pages: 1162 - 1171
A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation Wu PengXin ZhangGeorge L. Spitalny Original Article 22 April 2005 Pages: 1172 - 1179
Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: Therapeutic effect against cervical cancer Zhengrong CuiLeaf Huang Original Article 22 April 2005 Pages: 1180 - 1190
Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts Hiroshi IshiguroTakashi KishimotoHiroshi Ishikura Original Article 22 April 2005 Pages: 1191 - 1199
90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas Angela ColivaAlberto ZacchettiSilvana Canevari Original Article 31 May 2005 Pages: 1200 - 1213
A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells Sabrina OttavianiYi ZhangPierre van der Bruggen Original Article 16 July 2005 Pages: 1214 - 1220
